Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06753253 · ClinicalTrials.gov registry record · NA

Effects of Exercise Intensity on ADHD Symptoms

A NA study of Attention Deficit Hyperactivity Disorder and ADHD, sponsored by Kent State University.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT06753253: Completed NA study of Attention Deficit Hyperactivity Disorder and ADHD, sponsored by Kent State University.

NCT06753253 is a NA study of Attention Deficit Hyperactivity Disorder and ADHD that has completed, run by Kent State University. The registered enrollment target is 28 participants, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06753253, a NA study of Attention Deficit Hyperactivity Disorder and ADHD, has completed, sponsored by Kent State University.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

This project investigates the effects of a bicycling exercise at three levels of exercise intensity (low, moderate, and high) on attention deficit/hyperactivity disorder (ADHD) in college students. Specifically, the outcomes of interest in this study are self-reported executive functioning, self-reported functional impairment, and ADHD symptom severity. The hypothesis is that exercise will improve executive functioning, while reducing functional impairment and ADHD symptom severity, and that this response will be most pronounced in the high-intensity exercise group.

Primary Outcome

Self-reported executive function will be measured using a modified version of the Barkley Executive Function Scale (BDEFS)

Conditions Studied

Attention Deficit Hyperactivity Disorder ADHD Attention Deficit Disorder With Hyperactivity

Interventions

  • BEHAVIORAL Cycling Exercise

Study Locations (1)

Ohio

  • Kent State University - Kent

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2024-08-06
Est. Completion 2024-11-25
Phase NA
Kent State University

19 total trials

What the finished NCT06753253 record still lists

NCT06753253 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (87% lower).

The record links to 3 conditions, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which Cycling Exercise is the first listed.

NCT06753253 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06753253 about?

NCT06753253 is a clinical study titled "Effects of Exercise Intensity on ADHD Symptoms". This project investigates the effects of a bicycling exercise at three levels of exercise intensity (low, moderate, and high) on attention deficit/hyperactivity disorder (ADHD) in college students. Specifically, the outcomes of interest in this study are self-reported executive functioning, self-rep...

What is the current status of trial NCT06753253?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2024-08-06. Estimated completion is 2024-11-25.

What conditions does trial NCT06753253 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder, ADHD, Attention Deficit Disorder With Hyperactivity.

What interventions are being tested in trial NCT06753253?

The interventions under investigation include: Cycling Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT06753253?

This trial is sponsored by Kent State University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06753253 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06753253's enrollment target sits among peer trials

28 90th of 102 higher than 11 of 102 other Attention Deficit Hyperactivity Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06753253, the US trial registry maintained by the National Library of Medicine. NCT06753253 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.